Cara Therapeutics Inc. (CARA) was a big mover last session, as the company saw its shares surge over 19% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 28.28% in the past one-month time frame.
In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged. However, Friday’s price action is encouraging, so make sure to keep a close watch on this firm in the near future.
Cara Therapeutics Inc. currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other players in the healthcare industry include Illumina Inc. (ILMN), Gilead Sciences Inc. (GILD) and ANI Pharmaceuticals, Inc. (ANIP) all carrying a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment